DFP Healthcare Acquisitions Cor
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $161.3M | $147.4M | $142.0M | $136.6M | $119.8M | $104.4M | $100.3M | $99.9M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $29.9M | $28.2M | $28.0M | $25.3M | $26.9M | $25.4M | $24.9M | $26.6M |
| Operating Income | $-4.6M | $-6.5M | $-6.9M | $-8.1M | $-11.2M | $-9.9M | $-11.9M | $-13.9M |
| Operating Margin | -2.9% | -4.4% | -4.9% | -5.9% | -9.4% | -9.5% | -11.9% | -13.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-9.8M | $-2.5M | $-7.5M | $-16.5M | $-17.1M | $-19.6M | $-13.2M | $-16.1M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $-131.0K | $0 | $0 | $0 |
| Net Income | $-9.8M | $-2.5M | $-7.5M | $-16.5M | $-17.0M | $-19.6M | $-13.2M | $-16.1M |
| Net Margin | -6.1% | -1.7% | -5.3% | -12.1% | -14.2% | -18.8% | -13.1% | -16.1% |
| EPS (Basic) | $-0.08 | $-0.02 | $-0.04 | $-0.14 | $-0.15 | $-0.21 | $-0.14 | $-0.18 |
| EPS (Diluted) | $-0.08 | $-0.02 | $-0.04 | $-0.14 | $-0.15 | $-0.21 | $-0.14 | $-0.18 |
| Shares Outstanding (Basic) | 103.0M | 101.8M | 92.4M | 97.5M | 93.2M | 77.1M | 75.0M | 75.5M |
| Shares Outstanding (Diluted) | 103.0M | 101.8M | 92.4M | 97.5M | 93.2M | 77.1M | 75.0M | 75.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |